According to the World Health Organization (WHO) joint pain and musculoskeletal injuries are the most common cause of severe long-term pain and physical disability. Soft tissue injuries including tendon and ligament trauma accounts for 45% of all musculoskeletal injuries in Newnan and the rest of the USA.
Several clinical studies agree that Platelet Rich Plasma has been shown to be safe and effective in treating joint pain and the following common conditions:
The procedure is less aggressive and less expensive than surgery. It will heal tissue with minimal or no scarring, and alleviates further degeneration of the tissues. No ill effects have been reported in any of the many studies executed. This process uses the patient’s own blood thereby eliminating any chance of rejection response and minimizes the likelihood of infection.
Platelet rich plasma (PRP) is not covered by insurances, but due to the popularity and publication of use by many professional athletes, the demand for its use is great.
Clinical Studies for Joint Pain
Effect of intra-articular injection of platelet-rich plasma on interleukin-17 expression in synovial fluid and venous plasma of Knee Osteoarthritis patients and patients with joint pain.
Clinical Results of Platelet-Rich Plasma for Partial Thickness Rotator Cuff Tears: A Case Series
A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating Meniscal Healing,Clinical Outcomes, and Safety in Patients Undergoing Meniscal Repair of Unstable, Complete Vertical Meniscal Tears (Bucket Handle) Augmented with Platelet-Rich Plasma
The Effectiveness of Platelet-Rich Plasma Injections in Gluteal Tendinopathy: A Randomized, Double-Blind Controlled Trial Comparing a Single Platelet-Rich Plasma Injection With a Single Corticosteroid Injection.